These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8264144

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H.
    Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P.
    Miner Electrolyte Metab; 1996 Aug 15; 22(1-3):26-30. PubMed ID: 8676820
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma lipoprotein (a) levels in children with minimal lesion nephrotic syndrome.
    Nakahara C, Kobayashi K, Hamaguchi H, Kanemoto K, Kashiwagi R, Matsui A.
    Pediatr Nephrol; 1999 Oct 15; 13(8):657-61. PubMed ID: 10502122
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD, Azrolan N, Thomas L, Roberts KG, Bostom A, Zhao ZH, Friedman EA.
    Am J Kidney Dis; 1995 Jul 15; 26(1):170-7. PubMed ID: 7611249
    [Abstract] [Full Text] [Related]

  • 9. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C.
    Clin Chem; 1995 Jun 15; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [Abstract] [Full Text] [Related]

  • 10. [Serum lipoprotein abnormalities in patients with nephrotic syndrome and effects of steroid therapy].
    Kohtoku N, Okuda F, Shimizu K, Takagi H, Fujii Z, Fujii H, Kusukawa R.
    Nihon Jinzo Gakkai Shi; 1989 Apr 15; 31(4):335-44. PubMed ID: 2747006
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated serum β₂-GPI-Lp(a) complexes levels in children with nephrotic syndrome.
    Zhang C, Luo Y, Huang Z, Xia Z, Cai X, Yang Y, Niu D, Wang J.
    Clin Chim Acta; 2012 Oct 09; 413(19-20):1657-60. PubMed ID: 22609258
    [Abstract] [Full Text] [Related]

  • 15. The level of native and oxidized lipoprotein(a) in children with nephrotic syndrome.
    Li HQ, Wu J, Niu DM, Shi YH, Zhang CN, Wang JJ.
    Clin Biochem; 2012 Jan 09; 45(1-2):101-5. PubMed ID: 22122998
    [Abstract] [Full Text] [Related]

  • 16. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
    Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RP.
    Nephrol Dial Transplant; 1994 Jan 09; 9(3):244-50. PubMed ID: 8052429
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P, Lu L, Hu B, Du PF.
    Scand J Clin Lab Invest; 2009 Jan 09; 69(6):680-6. PubMed ID: 19468931
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein(a) levels in the nephrotic syndrome.
    Kanno H, Saito E, Fujioka T, Yasugi T.
    Intern Med; 1992 Aug 09; 31(8):1004-8. PubMed ID: 1477459
    [Abstract] [Full Text] [Related]

  • 19. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J, Mirzaian Y, Grabensee B.
    Nephrol Dial Transplant; 1996 Jun 09; 11(6):1034-42. PubMed ID: 8671965
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, König P, Thiery J, Koch M, von Eckardstein A, Dieplinger H.
    Kidney Int; 2004 Jul 09; 66(1):348-54. PubMed ID: 15200443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.